Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service

British Journal of Ophthalmology

Volumn 99, Issue 1, 2015, Pages 64-68

  Thomas, Rebecca L ^a   Dunstan, Frank D ^b   Luzio, Stephen D ^a   Chowdhury, Sharmistha Roy ^b   North, Rachel V ^b   Hale, Sarah L ^c   Gibbins, Robert L ^d   Owens, David R ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^d Retired GP   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; DIGITAL IMAGING; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEALTH SERVICE; HUMAN; IMAGE ANALYSIS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MYDRIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; QUALITY CONTROL; RISK FACTOR; SCREENING TEST; VISUAL ACUITY; ADOLESCENT; CHILD; CLASSIFICATION; COMPLICATION; MASS SCREENING; MIDDLE AGED; PHOTOGRAPHY; PROCEDURES; PUBLIC HEALTH; RISK; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; ODDS RATIO; PHOTOGRAPHY; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; WALES; YOUNG ADULT;

EID: 84919341098     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-304017     Document Type: Article

References (38)

1. Hammes HP, Kerner W, Hofer S, et al. Diabetic retinopathy in type 1 diabetes-A contemporary analysis of 8, 784 patients. Diabetologia 2011;54: 1977-84.
2. Olafsdottir E, Anderson DKG, Dedorsson I, et al. The prevalence of retinopathy in subjects with and without type 2 diabetes mellitus. Acta Ophthalmologica 2014;92: 133-7.
3. Looker HC, Nyangoma SO, Cromie D, et al. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia 2012;55: 2335-42.
4. Kohner EM, Aldington SJ, Stratton IM, et al. United Kingdom prospective diabetes study, 30 diabetic retinopathy at diagnosis of non-insulin-dependant diabetes mellitus and associated risk factors. Arch of Ophthalmol 1998;116: 297-303.
5. Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health 2006;6: 58.
6. Bunce C, Wormald R. Causes of blind certifications in England and Wales: April 1999-2000. Eye 2008;22: 905-11.
7. Shirasawa M, Arimura N, Otsuka H, et al. Intravitreous VEGF-A in eyes with massive vitreous hemorrhage. Graefe's Arch Clin Exp Ophthalmol 2011;249: 1805-10.
8. Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 2010;304: 649-56.
9. A protocol for screening for diabetic retinopathy in Europe. Retinopathy Working Party. Diabetic Med 1991;8: 263-7.
10. Buxton MJ, Sulpher MJ, Ferguson BA, et al. Screening for treatable diabetic retinopathy: A comparison of different methods. Diabetic Med 1991;8: 371-7.
11. Burnett S, Hurwitz B, Davey C, et al. The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of North London: A quality of care study. Diabetic Med 1998;15(Suppl 3): S38-43.
12. Younis N, Broadbent D, James M, et al. Current status of screening for diabetic retinopathy in the UK. Diabetic Med 2002;19(S4): 44-9.
13. Leese GP, Morris AD, Olson J. A national retinal screening programme for diabetes in Scotland. Diabetic Med 2003;20: 962-4.
14. Boucher MC, Nguyen QT, Angioi K. Mass community screening for diabetic retinopathy using a nonmydriatic camera with telemedicine. Can J Ophthalmol 2005;40: 734-42.
15. Olafsdottir E, Stefansson E. Biennial eye screening in diabetic patients without retinopathy. 10 year experience. Brit J Ophthalmol 2007;91: 1599-601.
16. Bloomgarden ZT. Screening for and managing diabetic retinopathy: Current approaches. Am J Health-Syst Ph 2007;64(17 Suppl 12): S8-14.
17. Scanlon PH. The English national screening programme for sight-threatening diabetic retinopathy. J Med Screen 2008;15: 1-4.
18. Beynat J, Charles A, Astruc K, et al. Screening for diabetic retinopathy in a rural French population with a mobile non-mydriatic camera. Diabetes Metab 2009;35: 49-56.
19. Chabouis A, Berdugo M, Meas T, et al. Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: A retrospective study in five reference hospital centres. Diabetes Metab 2009;35: 228-32.
20. Garvican L, Clowes J, Gillow T. Preservation of sight in diabetes: Developing a national risk reduction programme. Diabetic Med 2000;17: 627-34.
21. National Institute for Clinical Excellence. Clinical Guideline 15: Type 1 diabetes: Diagnosis and management of type 1 diabetes in children, young people and adults. London: NICE, 2004.
22. Lueder GT, Silverstein J. Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics 2005;116: 270-3.
23. Facey K, Cummins E, Macpherson K, et al. Organisation of Services for Diabetic Retinopathy Screening. Health Technology Assessment Report 1. Health Technology Board for Scotland, 2002.
24. Welsh Government. Population of Wales an Overview. 2012 [31/7/2012]. http://www.statswales.wales.gov.uk/TableViewer/document.aspx?ReportId=10475
25. http://www.diabetes.org.uk/Professionals/Publications-reports-and-resources/Reports-statistics-and-case-studies/Reports/Diabetes-prevalence-2010/
26. Gibbins RL. An evaluation of methods of community based screening and surveillance for diabetic retinopathy. MD: University of Cambridge, 1999.
27. Yau JWY, Rogers SL, Kawasaki R, et al.; The Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35: 556-64.
28. Early Treatment Diabetic Retinopathy Research Study Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House Classification. ETDRS report number 10. Ophthalmology 1991;98: 786-806.
29. Harding S, Greenwood R, Aldington S, et al. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabetic Med 2003;20: 965-71.
30. UK National Screening Committee. Essential elements in developing a Diabetic Retinopathy screening programme. Workbook 4.4 ed2009.
31. Kristinsson JK, Stefansson E, Jonasson F, et al. Screening for eye disease in type 2 diabetes mellitus. Acta Ophthalmol Scand 1994;72: 341-46.
32. Misra A, Bachmann MO, Greenwood RH, et al. Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. Diabetic Med 2009;26: 1040-7.
33. Younis N, Broadbent DM, James M, et al. Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme. Diabetic Med 2002;19: 1014-21.
34. Kristinsson JK, Stefansson E, Jonasson F, et al. Systematic screening for diabetic eye disease in insulin dependent diabetes. Acta Ophthalmologica 1994;72: 72-8.
35. American Diabetes Association. Clinical Practice Recommendations. Diabetes Care 2010;33(Suppl 1): S11-61.
36. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102: 527-32.
37. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102: 520-6.
38. UK prospective diabetes study group (UKPDS)Adler AI, Stratton IM, Neil HAW, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes: Prospective observational study. Brit Med J 2000;321: 412-19.